Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Imunon, Inc.

CIK 749647 IMNN·Pharmaceutical Preparations · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K
  2. SEC comment letter CORRESP +6d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Finance chief departure elevated Filing comparison

Imunon, Inc.'s Chief Financial Officer departed, replaced on an interim basis

Evidence
Interim only
Yes
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
elevated
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗

SEC comment letter Filing comparison

Imunon, Inc. responded to SEC staff comments on MD&A

Letter dated 2025-08-13; published on EDGAR 2026-01-13 — the SEC releases comment letters only after the review closes.

Please revise future filings in an appropriate place to include a discussion of the material terms of these or any other material license agreements, including, as applicable: ● Nature and scope of intellectual property transferred; ● Each parties’ rights and obligations; ● Duration of agreement and royalty term; ● Termination provisions; and ● Payment provisions, including quantification of any upfront fee and any…
Evidence
Direction
company to staff
Letter dated
2025-08-13
Published on edgar
2026-01-13
Reviewing
Imunon, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 Filed February 27, 2025 File No. 001-15911 Dear Ms. Hamill and Mr. Drory: On behalf of Imunon, In
Source
Company response to SEC staff (CORRESP)
Topics
MD&A
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.

Source filing ↗

Finance chief departure elevated Filing comparison

Imunon, Inc.'s Chief Financial Officer departed, replaced on an interim basis

Evidence
Interim only
Yes
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
elevated
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗